Supriya Lifescience Ltd share price logo

Supriya Lifescience Ltd (SUPRIYA)

₹390.651.93%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Analyst Rating

based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Supriya Lifescience Ltd. An average target of ₹401

Source: S&P Global Market Intelligence

Supriya Lifescience Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹389
    ₹401.15
  • 52 Week's Low

    52 Week's High

    ₹233.3
    ₹424.7
1 Month Return+ 1.73 %
3 Month Return+ 7.44 %
1 Year Return+ 63.86 %
Previous Close₹398.35
Open₹399.95
Volume1.62L
Upper Circuit-
Lower Circuit-
Market Cap₹3,206.03Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹3,206.03 Cr
P/B Ratio2.19
EPS0

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Motilal Oswal Nifty Microcap 250 Index Fund Direct GrowthMotilal Oswal Nifty Microcap 250 Index Fund Direct Growth0.15%
WhiteOak Capital Pharma and Healthcare Fund Direct GrowthWhiteOak Capital Pharma and Healthcare Fund Direct Growth1.09%
Quantum Small Cap Fund Direct GrowthQuantum Small Cap Fund Direct Growth1.65%
Groww Nifty Total Market Index Fund Direct GrowthGroww Nifty Total Market Index Fund Direct Growth0.01%

Company Information

Supriya Lifescience Limited is an Indian manufacturing company and supplier of active pharmaceutical ingredients (APIs). As of 31 March 2021, the company has offered 39 APIs with a focus on therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics and anti-allergies. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India - 4555 and 6570 units, respectively - between Fiscal 2017 and 2020. Supriya Lifescience has sought approval for its products from international regulatory authorities including the USFDA, EUGMP and EDQM, and is supported by a modern manufacturing facility. Two new clean rooms are set to be powered up in the first quarter of Fiscal 2022. Over the years, the company has issued 3002400, 1626302, 9757804 Equity shares and increased its face value from Rs 10 to Rs 2 per share. In December 2021, Supriya Lifescience Limited conducted a Rs 700 crores public issue and the allotted shares were listed on BSE Ltd and NSE.

Share Price: ₹390.65 per share as on 12 Jul, 2024 04:01 PM
Market Capitalisation: ₹3,206.03Cr as of today
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
OrganisationSupriya Lifescience Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Supriya Lifescience Ltd

  • Supriya Lifescience Beats Revenue and EBITDA Estimates - 13 Jun, 2024

    Supriya Lifescience's revenue beat estimates by 5.8% due to growth in Vitamin and Anti-Histamine segment, while EBITDA beat estimates by 22.4% due to lower expenses. The stock is trading at 19.3x/15.6x based on FY25E/FY26E EPS respectively, with a target price of INR 401/share and a BUY rating. Regulated market share expected to increase, watch for Ambernath facility commencement, new product launches, and commercialized contracts.

  • Supriya Lifescience Ltd's Cash Conversion Less Than Ideal - 05 Jun, 2024

    Supriya Lifescience Limited's accrual ratio for the last twelve months signifies cash conversion is less than ideal, which is a negative when it comes to our view of its earnings. Its earnings per share increased by 33% in the last year. However, the company had negative free cash flow of ₹323m despite its profit of ₹1.19b, which might indicate high risk.

  • Supriya Lifescience Reports Strong FY 2024 Earnings - 30 May, 2024

    Supriya Lifescience reported a strong FY 2024 with an EPS of ₹14.80, up from ₹11.17 in FY 2023. The company's revenue and net income increased by 26% and 33%, respectively, compared to the previous year. Looking ahead, revenue is forecasted to grow at 18% p.a., higher than the industry average of 10%. However, the stock price has dropped by 6.5% from a week ago.

Insights on Supriya Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.56% to 5.36% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.04% to 0.05% in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 98.7% return, outperforming this stock by 34.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.30% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.76% to 21.04% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SUPRIYA stock has moved down by -5.7%

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹823.46Cr
↑11.71%
Total Liabilities
₹124.00Cr
↑2.10%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹66.19Cr
↑35.64%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
68.3%
0.00
Foreign Institutions
5.36%
0.00
Mutual Funds
0.05%
0.00
Retail Investors
21.04%
0.00
Others
5.25%
0.00

Key Indicators

Earnings and Dividends

  • Supriya Lifescience Ltd Earnings Results

    Supriya Lifescience Ltd’s net profit fell -3.4% since last year same period to ₹36.93Cr in the Q4 2023-2024. On a quarterly growth basis, Supriya Lifescience Ltd has generated 23.97% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Supriya Lifescience Ltd Dividends May,2023

    In the quarter ending March 2023, Supriya Lifescience Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.15%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Supriya Lifescience Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Supriya Lifescience Ltd shares.

Supriya Lifescience Ltd (SUPRIYA) share price today is ₹390.65

Supriya Lifescience Ltd is listed on NSE

Supriya Lifescience Ltd is listed on BSE

  • Today’s highest price of Supriya Lifescience Ltd is ₹401.15.
  • Today’s lowest price of Supriya Lifescience Ltd is ₹389.

Today’s traded volume of Supriya Lifescience Ltd(SUPRIYA) is 1.62L.

Today’s market capitalisation of Supriya Lifescience Ltd(SUPRIYA) is ₹3206.03Cr.

Supriya Lifescience Ltd(SUPRIYAPrice
52 Week High
₹424.7
52 Week Low
₹233.3

Supriya Lifescience Ltd(SUPRIYA) share price is ₹390.65. It is down -8.02% from its 52 Week High price of ₹424.7

Supriya Lifescience Ltd(SUPRIYA) share price is ₹390.65. It is up 67.45% from its 52 Week Low price of ₹233.3

Supriya Lifescience Ltd(SUPRIYAReturns
1 Day Returns
-7.7%
1 Month Returns
1.73%
3 Month Returns
7.44%
1 Year Returns
63.86%